Jennifer Cote
Chief Financial Officer at Harvard Bioscience Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Harvard Bioscience Inc., 2 years.
Harvard Bioscience Inc.
Director · Chief Financial Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2025 | Harvard Bioscience Inc. | Shares withheld for tax | −5,687 | $0.69 | $3,924 |
| Dec 29, 2024 | Harvard Bioscience Inc. | Shares withheld for tax | −4,731 | $1.98 | $9,367 |
| Dec 29, 2024 | Harvard Bioscience Inc. | Shares withheld for tax | −3,797 | $1.98 | $7,518 |
| Mar 6, 2024 | Harvard Bioscience Inc. | Shares withheld for tax | −9,920 | $4.11 | $40,771 |
| Mar 5, 2024 | Harvard Bioscience Inc. | Grant or award | +35,800 | — | — |
| Mar 5, 2024 | Harvard Bioscience Inc. | Grant or award | +35,800 | — | — |
| Dec 29, 2023 | Harvard Bioscience Inc. | Shares withheld for tax | −3,279 | $5.35 | $17,543 |
| Dec 29, 2023 | Harvard Bioscience Inc. | Shares withheld for tax | −2,631 | $5.35 | $14,076 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.